Skip to content

Buy ANY 5 Biomaterial Products, Receive 1 at No Cost! Use code B5G1Q125 Learn More

GEM 21S^®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More

Bone Substitutes
Membranes
- Geistlich Bio-Gide^®
- RPM™
Matrices
- Geistlich Fibro-Gide^®
- Geistlich Mucograft^®
Bone Harvesting
- Instruments
3D Titanium Scaffold
- Yxoss CBR^®
Membrane Fixation
- MC Bio Supertack
Growth Factors
- GEM 21S^®

Product Support
Young Professionals
Geistlich Guarantee
Geistlich Knowledge Bites Program
Newsroom

GROW
Clinical Resources
Treatment Solutions

Account

Search For:

Clinical Resources

Use the search and filter form below to find informative clinical content by format, therapeutic areas, or product.

FEATURED RESOURCE

Therapeutic Areas
- Extraction Socket Management(27)
- Major Bone Augmentation(36)
- Minor Bone Augmentation(21)
- Peri-Implantitis(6)
- Periodontal Regeneration(9)
- Sinus-Floor Elevation(5)
- Soft-Tissue Regeneration(58)
Products
- Geistlich Bio-Gide Compressed®(2)
- Geistlich Bio-Gide Shape®(1)
- Geistlich Bio-Gide®(55)
- Geistlich Bio-Oss Collagen®(24)
- Geistlich Bio-Oss Pen®(1)
- Geistlich Bio-Oss®(67)
- Geistlich Fibro-Gide®(37)
- Geistlich Mucograft®(25)
- Geistlich Mucograft® Seal(3)
- GEM 21S®(12)
- Micross(1)
- RPM™(1)
- Safescraper Twist(4)
- vallomix™(4)
- vallos®(9)
- vallos®f(2)
- Yxoss CBR®(14)

Found 139 Results

1 - Clinical situation in the posterior maxilla depicting a large buccal defect in the edentulous area.

2 - Fixation of the autologous block from the symphysis.

3 - Contouring of the grafted site with Geistlich Bio-Oss®.

4 - The augmented area is covered with the collagen membrane Geistlich Bio-Gide®.

5 - Primary wound closure is accomplished with single interrupted sutures.

6 - Clinical aspect of the augmented ridge with no signs of block resorption.

7 - Implant placement 3 months post augmentation.

8 - Long-term follow-up showing stable peri-implant bone level 3 years after implant placement.

A mid-facial incision was made, with the intent to preserve the minimal keratinized tissue that was available, as well as vertical incisions along the line angles of the canines to reflect a partial thickness flap.

Platelet-rich fibrin clots were formed by centrifugation. The leukocyte-PRF (L-PRF) was extracted, and the L-PRF was used to hydrate Geistlich Mucograft®

Geistlich Mucograft® and PRF stabilized via glycolon sutures.

Clinical situation at three-week follow-up.

Occlusal view at twelve-month follow-up.

Frontal view at twelve-month follow-up.

1 - Thin mucosal tissue over implant #7 creating an unesthetic appearance.

2 - Occlusal view of #7 reveals buccal soft-tissue defects.

3 - Augmentation of the soft-tissue on two implant sites, #7 and #10, using a conventional full thickness flap with vertical releasing incisions on site #7 and an envelope flap on site #10.

4 - Geistlich Fibro-Gide® is split into two 3mm thick matrices to be used in both sites, hydrated with sterile saline and trimmed to the defect dimensions.

5 - Geistlich Fibro-Gide® is secured to the periosteum apically and the interproximal papillae with 5-0 chromic gut sutures.

6 - Passive closure of the flap achieved with 6-0 vicryl sutures.

7 - 1 week post-surgery reveals uneventful healing with maintenance of tissue volume.

8 - Buccal view at 8 weeks reveals uneventful healing with maintenance of tissue volume.

9 - Occlusal view at 8 weeks post-surgery.

Page 3 of 12

Let's Stay Connected. (Enter Email) *

Contact

Geistlich Pharma North America Inc.
400 Alexander Park Drive, Suite 302
Princeton, NJ 08540

Customer Care Toll-free 855-799-5500
[email protected]

Help

Disclaimer
Shipping and Returns
Privacy Policy

Account

Login / Create Account

Company

Geistlich Pharma North America Inc.
Contact

These product(s) and promotion(s) are ONLY available within the North American Dental Markets (US & Canada). Promotions may vary in Canada and Puerto Rico. Please consult our exclusive Canadian distribution partner, HANSAmed Limited, for more details.

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.

© 2011 - 2025 Geistlich Pharma North America, Inc.